1375108-29-4 Usage
Description
7-bromo-3-fluoroquinoline is a fluoroquinoline-based organic compound characterized by a quinoline core, which is a fused benzene and pyridine ring system. This halogenated derivative features both a bromine and a fluorine atom in its structure, contributing to its potential biological activity. It is recognized for its utility in the synthesis of pharmaceuticals and agrochemicals, making it a significant molecule in medicinal chemistry and drug discovery.
Uses
Used in Pharmaceutical Synthesis:
7-bromo-3-fluoroquinoline is utilized as a key building block in the development of various pharmaceuticals. Its unique structure and halogenated nature facilitate its incorporation into drug molecules, enhancing their therapeutic properties and targeting specific biological pathways.
Used in Agrochemical Development:
In the agrochemical industry, 7-bromo-3-fluoroquinoline serves as a valuable intermediate for the synthesis of bioactive compounds. Its chemical properties allow for the creation of effective pesticides and other agrochemicals that can protect crops and enhance agricultural productivity.
Used in Medicinal Chemistry Research:
7-bromo-3-fluoroquinoline is employed as a research tool in medicinal chemistry to explore its potential as a precursor to new drug candidates. Its structural features and reactivity make it an attractive molecule for studying structure-activity relationships and optimizing drug design.
Used in Drug Discovery:
As a component of drug discovery efforts, 7-bromo-3-fluoroquinoline is leveraged for its potential to contribute to the development of novel therapeutic agents. Its presence in drug molecules can impart beneficial pharmacological properties, such as improved potency, selectivity, and pharmacokinetics.
Overall, 7-bromo-3-fluoroquinoline's diverse applications across pharmaceuticals, agrochemicals, medicinal chemistry research, and drug discovery underscore its importance and versatility in the field of chemistry and biology.
Check Digit Verification of cas no
The CAS Registry Mumber 1375108-29-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,5,1,0 and 8 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1375108-29:
(9*1)+(8*3)+(7*7)+(6*5)+(5*1)+(4*0)+(3*8)+(2*2)+(1*9)=154
154 % 10 = 4
So 1375108-29-4 is a valid CAS Registry Number.
1375108-29-4Relevant articles and documents
3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF M4 MUSCARINIC ACETYLCHOLINE RECEPTOR
-
, (2020/05/28)
Provided are cinnolinyl and quinolinyl pyrazol-4-yl-pyridine compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor, compositions comprising said compounds, and uses of said compounds in the treatment or prevention of diseases in which M4 muscarinic acetylcholine receptors are involved, especially neurological and psychiatric disorders and diseases.
FATTY ACID SYNTHASE INHIBITORS
-
Page/Page column 39, (2014/07/23)
This invention relates to triazolones and triazolones for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of triazolones in the treatment of cancer.
FATTY ACID SYNTHASE INHIBITORS
-
Paragraph 117-118, (2013/03/26)
This invention relates to spirocyclic piperidines according to Formula (I) and the use of spirocyclic piperidines for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of spirocyclic piperidines in the treatment of cancer.
